fund
JPM UK Equity Core E
A low cost actively managed UK equity fund.
-
57.92p
Price (Inc)
These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.
-
366.20p
Price (Acc)
These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?
-
0.00%
Initial chargeSome funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!
-
0.25%
Annual management charge
This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).
-
0.40%
Ongoing charges
This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.
-
4.20%
Yield
How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…
This fund targets capital growth over the long term by investing in the equities of UK companies. The fund aims to be a low cost, actively managed alternative to tracker funds. The managers will take a conservative approach and expect returns to be similar to those of the FTSE All-Share index, but aim to beat it. Target outperformance is at least 0.50% per annum, with returns above this subject to a performance fee.
Fund summary
| Sector | UK All Companies |
| Structure | OEIC |
| Launched | February, 2011 |
| Size | £1,359m |
| Yield | 4.20% |
| Charging basis | |
| Dividends paid | 30 Apr |
Charges
| Standard initial charge | 0.00% |
| Initial charge via Bestinvest | 0.00% |
| Additional bid/offer spread | 0.00% |
| Annual management charge | 0.25% |
| Ongoing charges figure | 0.40% |
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Investment process
The Fund aims to provide capital growth and outperform the FTSE All-Share Index over the long term by investing primarily in a portfolio of UK companies.
Manager research
Average monthly relative returns
- 16/17 -0.07%
- 17/18 0.02%
- 18/19 -0.13%
- 19/20 0.11%
- 20/21 -0.01%
Bestinvest MRI
- 3 years -0.01%
- 5 years -0.02%
- Career -0.02%
- 3 years 62.60%
- 5 years 56.80%
- Career 71.90%
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
Michael Barakos
Barakos is a Chief Investment Officer within the JPMorgan Asset Management European Equity Group. He has been an employee since 1999. Michael obtained a B.Sc. (Hons) in Economics from the London School of Economics & Political Science. He is a CFA charter holder.
Track record
Michael Barakos has 11.8 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been -0.02%. During the worst period of relative performance (from March 2009 - November 2011) there was a decline of 9% relative to the index. The worst absolute loss has been 26%.
Periods of worst performance
| Absolute | -26.00% (December 2019 - March 2020) |
| Relative | -9.00% (March 2009 - November 2011) |
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Top 10 holdings
Data accurate as at 31 July 2020
| 5.8% | Astrazeneca Plc |
| 4.2% | Royal Dutch Shell Plc |
| 3.7% | Glaxosmithkline |
| 3.3% | Jpm Uk Smaller Companies A Acc |
| 3.2% | Hsbc Hldgs |
| 3.1% | British American Tobacco |
| 2.9% | Diageo |
| 2.8% | Bp |
| 2.7% | Rio Tinto |
| 2.4% | Reckitt Benckiser Group Plc |
| Source: Trustnet |
Sector breakdown
| Biotechnology/Medical | 10.00% |
| Money Market | 7.00% |
| Mineral Extraction | 7.00% |
| Oil & Gas Exploration & Production | 7.00% |
| Banks | 6.00% |
| Support Services | 5.00% |
| Financial Services | 4.00% |
| Household Goods | 4.00% |
| Equities | 4.00% |
| Tobacco | 4.00% |